Company: TVRD
Filing Date: 2025-01-27
Form Type: S-4/A
Source: 0001104659-25-006050
Chunk: 719

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-01-27
Form: S-4/A
Chunk 719
---
 other 
 observable        
 inputs            
 (Level 2)         
 ​                 |      ​ | ​ 
 ​ 
 ​ 
 ​ | ​            
 Significant  
 unobservable 
 inputs       
 (Level 3)    
 ​            | ​ |
|:------------------------------------------|:--|:------|--------:|:--|:-------------------|-------:|:--|:------------------|-------:|:--|:-------------|:--|
| Money market funds and checking accounts  | ​ | $     |  51,775 | ​ | $                  | 51,775 | ​ | $                 |      — | ​ | $            | — |
| Available-for-sale marketable securities: | ​ |       |         | ​ |                    |        | ​ |                   |        | ​ |              |   |
| U.S. Treasury securities                  | ​ |       |  37,246 | ​ |                    |      — | ​ |                   | 37,246 | ​ |              | — |
| U.S. government agency obligations        | ​ |       |   7,238 | ​ |                    |      — | ​ |                   |  7,238 | ​ |              | — |
| Corporate bonds                           | ​ |       |   4,499 | ​ |                    |      — | ​ |                   |  4,499 | ​ |              | — |
| Restricted cash:                          | ​ |       |         | ​ |                    |        | ​ |                   |        | ​ |              |   |
| Commercial money market account           | ​ |       |   1,908 | ​ |                    |  1,908 | ​ |                   |      — | ​ |              | — |
| Total financial assets                    | ​ | $     | 102,666 | ​ | $                  | 53,683 | ​ | $                 | 48,983 | ​ | $            | — |

There werenopurchases, sales ormaturitiesof Level 3 financial assets andnounrealized gains or losses related to Level 3 available-for-sale marketable securities during each of the three and nine months ended September30, 2024 and 2023. There werenotransfers of financial assets into or out of Level 3 classification during each the three and nine months endedSeptember 30, 2024 and 2023.

F- 14

CARA THERAPEUTICS, INC. NOTES TO CONDENSED FINANC